Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Packer

Showing results (591-600 of 706) with videos related to

Pageof 71
Sort By:
Pediatric Blood & Cancer|September 6, 2012
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology GroupJames H Garvin, Michael T Selch, Emi Holmes, et al.
Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.
Journal of Neuro-Oncology|October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium studyKatherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Journal of Neuro-Oncology|November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC studyRoger J Packer, Brian R Rood, David C Turner, et al.
Neuro-Oncology|October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study reportElizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Cancer|May 15, 1996
Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II studyR J Packer, M Prados, P Phillips, et al.
The Journal of Pathology|May 19, 2023
Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusionMiriam Bornhorst, Augustine Eze, Surajit Bhattacharya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer GroupJ L Finlay, S Goldman, M C Wong, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 20, 2015
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumorsMark W Kieran, Susan Chi, Stewart Goldman, et al.
Pageof 71

Showing results (591-600 of 706) with videos related to

Sort By:
Pageof 71
Pediatric Blood & Cancer|September 6, 2012
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology GroupJames H Garvin, Michael T Selch, Emi Holmes, et al.
Neuro-Oncology|May 22, 2014
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine gliomaUte Bartels, Johannes Wolff, Lia Gore, et al.
Journal of Neuro-Oncology|October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium studyKatherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Journal of Neuro-Oncology|November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC studyRoger J Packer, Brian R Rood, David C Turner, et al.
Neuro-Oncology|October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study reportElizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Cancer|May 15, 1996
Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II studyR J Packer, M Prados, P Phillips, et al.
The Journal of Pathology|May 19, 2023
Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusionMiriam Bornhorst, Augustine Eze, Surajit Bhattacharya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer GroupJ L Finlay, S Goldman, M C Wong, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 20, 2015
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumorsMark W Kieran, Susan Chi, Stewart Goldman, et al.
Pageof 71